Nicholas O. Daneshvari, MD

Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts

  • 4Articles
  • 35.5KReads
  • 2024–2025Active
  • 7Collaborators
  • 2Citations

About

Nicholas O. Daneshvari, MD, is affiliated with the Department of Psychiatry at Massachusetts General Hospital and Harvard Medical School in Boston, Massachusetts. His publications from 2024 to 2025 focus on schizophrenia, schizoaffective disorders, movement disorders, and psychotic disorders. He has authored articles on pharmacologic strategies for psychotic illnesses, management of tardive dyskinesia, clozapine use and monitoring, and approaches to treatment-resistant schizophrenia. Frequent collaborators include Abigail L. Donovan, Carol S. Lim, Theodore A. Stern, Chirag M. Vyas, and Desta S. Lissanu.

Publications

PCC
Choosing a Pharmacologic Strategy for Psychosis
Rounds in the General Hospital

Choosing a Pharmacologic Strategy for Psychosis

October 28, 2025

Find out which antipsychotic agent to prescribe to your patient with psychosis and learn how to balance the concepts of efficacy, tolerability, and cost.
, , , et al
PCC
Etiology, Prevention, and Management of TD
Rounds in the General Hospital

Etiology, Prevention, and Management of TD

November 19, 2024

It is critical to detect TD early in its course and adjust medications to those that are less likely to cause it. Left untreated, TD is typically irreversible, disfiguring,...
, , , et al
PCC
Clozapine: Its Use and Monitoring
Rounds in the General Hospital

Clozapine: Its Use and Monitoring

July 30, 2024

The authors provide the latest information on clozapine use, including when your patients should receive or avoid taking it, what laboratory tests are required before and during administration, and...
, , , et al
PCC
Evaluation and Management of Treatment-Resistant Schizophrenia
Rounds in the General Hospital

Evaluation and Management of Treatment-Resistant Schizophrenia

July 2, 2024

If you have ever been uncertain about how to evaluate patients with a chronic psychotic illness or struggled over how best to manage treatment-resistant schizophrenia, then this case vignette...
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe